@FiercePharma: Merck's Tredaptive fiasco blamed on adverse reactions to niacin. Article | Follow @FiercePharma
@EricPFierce: Must be some folks sorry Mylan got Agila and they didn't. Hikma says it is getting interest in its injectables biz. Story | Follow @EricPFierce
> Anacor Pharmaceuticals ($ANAC) received upbeat results from the second of two Phase III trials of tavaborole, a topical anti-fungal for the treatment of onychomycosis, a common fungal nail infection in the U.S. Release
> The FDA has granted fast-track status for Cubist Pharmaceuticals' ($CBST) antibiotic ceftolozane/tazobactam to treat bacterial pneumonia and complicated urinary tract infections as well as ceftolozane/tazobactam and surotomycin for complicated intra-abdominal infections (cIAI) and Clostridium difficile-associated diarrhea, respectively. Release
> Novartis' ($NVS) drug Ilaris has been approved in Europe for patients with gout, an often painful type of inflammatory arthritis. Item
> Streamlining FDA processes and cutting inefficiencies could boost U.S. economy. Story
Biotech News
@FierceBiotech: From FierceBiotechIT.com : GSK jumps new IT hurdles in 'real-world' test of blockbuster hopeful. Editor's Corner | Follow @FierceBiotech
@JohnCFierce: Lundbeck gets EU nod for new drug to fight alcohol addiction--$300M tops; no U.S. plans. Story | Follow @JohnCFierce
@RyanMFierce: Alere grabbed some Gates Foundation funding for Tuberculosis and HIV testing products. Release | Follow @RyanMFierce
> As sequestration dawns, FDA supporters scramble to ease woes on drug reviews. Report
> Facebook, Google geeks 'hack' into cancer research problem with mobile game. More
> FDA pins approval on once-monthly version of blockbuster Abilify. Article
@FierceMedDev: Boston Scientific posts positive Watchman data. Item | Follow @FierceMedDev
@MarkHFierce: Fledgling Dx company GeneCentric is raising money to support a lung cancer Dx commercial launch. More | Follow @MarkHFierce
@DamianFierce: More worry for Intuitive Surgical as the FDA gets involved in the scrutiny of da Vinci robots. Story | Follow @DamianFierce
> Wright finalizes $190M-plus buy of BioMimetic. Story
> AtriCure 2012 losses, revenue grew as market push unfolded. Article
> Alere snags up to $42.2M from Gates Foundation for TB Dx. News
And Finally... EntreMed is raising $10.7 million of securities in a registered direct offering. Release